Spectral Medical Inc T.EDT

Next Week....

[mercedesman]

Should be Q4/2021 FS.   Likely uneventful in and of themselves, especially given some odd Revenue Recognition Policies (see tiny slivers on first Baxter tranche), and the lack of SAMI and EAA sales (seems that we prefer giveaways/loaners/etc. - to all those tire kickers and researchers)

Cash on Hand might be worth a look, in case the Cheif Enrichment Officer is looking to "up" his alotment as a kind of "up yours" to the ones that brung 'em (incl all those nice western folk).

However....

Most Important IMO will be an accompanying update on Tigris

• back on track?
• Worst Case Traking or Best Case?
• ETA on 60% enrollment ?
• update on Investigators Meeting ?
• upticks now that Covid spike has subsided?
• upticks re: Trial protocol Amendment re: SOFA announced Nov 2021?
• upticks re: 15 sites?
• continuing to exceed expectations?  What are expectations exactly?

These are the things upon which the 6 Million PSU's granted to the Locomotive Engineer and Conductor depend (most likely - although we may never know just how motivational they really are)

MM

[Domino55]

Cash on Hand is likely the most important disclosure. With the recent internal valuation of the sum total of Spectral at 32 cents per share (for dilution purposes at least) the "G" word comes to mind. ...for things like expanding the high performing Dialco sales force, hiring of directors (for what exactly again), improving on the already stellar IR and funding the uplist to Nasdaq that

[hmmmmmmmm]

Cash on hand? We all know the yearly raise is incoming. You don't have to run a head shop to be able to see the burn rate v. the trial progress. Last July we were at .55 the week before they raised by selling it off at .42 plus a half warrant.  and it's continued to tumble from there... If we're around .35 this year just think how cheap and how many millions they can "

[Domino55]

Please remained seated HMMMMM. Nothing to fear you scaredy cat. Shareholder interests are perfectly alingned. Insiders do not benefit from low share prices. Your best interests as a retail investor are in good hands. Calmness is required.